Published in Cancer Weekly, March 20th, 2012
"Randomised control trials typically have limited follow-up times, which restricts investigation of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.